Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Digital Chest Tube Drainage System (Thopaz+) Versus Analog in Pediatric Patients

NCT: NCT05511987 · RECRUITING

NCT IDNCT05511987
StatusRECRUITING
Start Date2023-08-15
Completion2027-12-01

Brief Summary

In 2007 the Thopaz digital drainage system was launched as one of the first chest tube drainage systems to utilize a digital rather than analog device. The digital system allows for stored data, objective measurement of air leaks as well as maintaining a constant pleural pressure. The adult literature describes multiple benefits of using a digital drainage system, only two studies to date have looked at pediatric patients. In the adult literature, reported benefits include shorter chest tube drainage times, decreased length of stay, cost savings and fewer chest x-rays. To date, there have been no prospective randomized controlled trials comparing digital versus analog chest tube drainage systems in pediatric patients. In addition, the only two pediatric studies which looked at the potential benefits of a digital drainage system only looked at its use in patients who underwent pulmonary resection. Thus, a gap in the literature exists for a prospective trial determining if there is benefit to using a digital vs analog drainage system in pediatric patients requiring a chest tube. The investigators hypothesize that pediatric patients who are placed on the Thopaz+ digital drainage system will have decreased duration of chest tube drainage, fewer chest x-rays and shorter duration of air leaks compared to patients using a traditional analog chest tube drainage system. This will be the first prospective randomized study exploring the potential benefits of using a digital chest tube drainage system in pediatric patients.

Frequently Asked Questions

What is Digital Chest Tube Drainage System (Thopaz+) Versus Analog in Pediatric Patients?

Digital Chest Tube Drainage System (Thopaz+) Versus Analog in Pediatric Patients is a clinical trial registered under NCT05511987. Current status: RECRUITING.

What is the status of NCT05511987?

The current status of NCT05511987 (Digital Chest Tube Drainage System (Thopaz+) Versus Analog in Pediatric Patients) is: RECRUITING.

When did Digital Chest Tube Drainage System (Thopaz+) Versus Analog in Pediatric Patients start?

Digital Chest Tube Drainage System (Thopaz+) Versus Analog in Pediatric Patients started on 2023-08-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.